BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 30362603)

  • 1. Oncostatic treatment effect of triple negative breast cancer cell line with copper (I)-nicotinate complex.
    Abdel-Mohsen MA; Toson EA; Helal MA
    J Cell Biochem; 2019 Mar; 120(3):4278-4290. PubMed ID: 30362603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor Activity of Copper (I)-Nicotinate Complex and Autophagy Modulation in HCC1806 Breast Cancer Cells.
    Abdel-Mohsen MA; Abdel Malak CA; Abou Yossef MA; El-Shafey ES
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1526-1536. PubMed ID: 28356017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells.
    Abdel-Mohsen MA; Abdel Malak CA; El-Shafey ES
    Adv Med Sci; 2019 Mar; 64(1):202-209. PubMed ID: 30798072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of copper(I) nicotinate complex on the Notch1 signaling pathway in triple negative breast cancer cell lines.
    Abdel-Mohsen MA; Badawy AM; Abu-Youssef MA; Yehia MA; Abou Shamaa LD; Mohamed SA
    Sci Rep; 2024 Jan; 14(1):2522. PubMed ID: 38291201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.
    Shahsavari Z; Karami-Tehrani F; Salami S; Ghasemzadeh M
    Tumour Biol; 2016 Apr; 37(4):4479-91. PubMed ID: 26496737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective and antioxidant effects of copper-nicotinate complex against glycerol-induced nephrotoxicity in rats.
    Medhat Hegazy A; Hafez AS; Eid RM
    Drug Chem Toxicol; 2020 May; 43(3):234-239. PubMed ID: 29944001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells.
    Fan L; Tian M; Liu Y; Deng Y; Liao Z; Xu J
    Oncotarget; 2017 May; 8(18):29823-29832. PubMed ID: 28415735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells.
    Raman V; Fuentes Lorenzo JL; Stashenko EE; Levy M; Levy MM; Camarillo IG
    Int J Oncol; 2017 Dec; 51(6):1801-1808. PubMed ID: 29075784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.
    Abdelhamed S; Yokoyama S; Refaat A; Ogura K; Yagita H; Awale S; Saiki I
    Anticancer Res; 2014 Apr; 34(4):1893-9. PubMed ID: 24692724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation.
    Choi C; Cho WK; Park S; Shin SW; Park W; Kim H; Choi DH
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Abiraterone Acetate Efficacy in Androgen Receptor-positive Triple-negative Breast Cancer: Chk1 as a Potential Target.
    Grellety T; Callens C; Richard E; Briaux A; Vélasco V; Pulido M; Gonçalves A; Gestraud P; MacGrogan G; Bonnefoi H; Cardinaud B
    Clin Cancer Res; 2019 Jan; 25(2):856-867. PubMed ID: 30352905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-apoptotic effect of Δ2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1.
    Geoffroy M; Kleinclauss A; Grandemange S; Hupont S; Boisbrun M; Flament S; Grillier-Vuissoz I; Kuntz S
    Breast Cancer Res Treat; 2017 Oct; 165(3):517-527. PubMed ID: 28681173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species.
    Richards CE; Vellanki SH; Smith YE; Hopkins AM
    Cell Oncol (Dordr); 2018 Feb; 41(1):35-46. PubMed ID: 29134467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide.
    Knickle A; Fernando W; Greenshields AL; Rupasinghe HPV; Hoskin DW
    Food Chem Toxicol; 2018 Aug; 118():154-167. PubMed ID: 29742465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picrasidine G decreases viability of MDA-MB 468 EGFR-overexpressing triple-negative breast cancer cells through inhibition of EGFR/STAT3 signaling pathway.
    Yamashita N; Kondo M; Zhao S; Li W; Koike K; Nemoto K; Kanno Y
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2608-2612. PubMed ID: 28427809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible Selective Cytotoxicity of Vanadium Complex on Breast Cancer Cells Involving Pathophysiological Pathways.
    El-Shafey ES; Elsherbiny ES
    Anticancer Agents Med Chem; 2019; 19(17):2130-2139. PubMed ID: 31696812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chetomin induces apoptosis in human triple-negative breast cancer cells by promoting calcium overload and mitochondrial dysfunction.
    Dewangan J; Srivastava S; Mishra S; Pandey PK; Divakar A; Rath SK
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1915-1921. PubMed ID: 29208466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
    Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
    Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway.
    Ono H; Sowa Y; Horinaka M; Iizumi Y; Watanabe M; Morita M; Nishimoto E; Taguchi T; Sakai T
    Breast Cancer Res Treat; 2018 Aug; 171(1):43-52. PubMed ID: 29752686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.